Literature DB >> 22529711

Overview of the clinical manifestations of Borrelia burgdorferi infection.

R J Dattwyler1, B J Luft.   

Abstract

Lyme disease, caused by the spirochete Borrelia burgdorferi, has classically been divided into three stages: erythema migrans; neurological or cardiac involvement; and arthritis. Rather than defining a set disease pattern, however, one should, more logically, conceptualize a progressive infection that may be localized or disseminated, acute or chronic. Erythema migrans, the earliest and most easily recognized manifestation of B burgdorferi infection, is an expanding annular erythematous skin lesion with a central clearing that develops soon after the bite of an infected ixodes tick. Musculoskeletal manifestations are common, with approximately one-half of untreated individuals developing arthritis. Of these, only 10% have chronic arthritis. Invasion of the central nervous system occurs as the infection disseminates hematogenously, with encephalitis, myelitis and meningopolyneuritis being the most severe results. Acute cardiac involvement is recognized in up to 8% of adult patients, and less often in children. Early antibiotic treatment of the infection is highly effective.

Entities:  

Keywords:  Clinical manifestations; Disease stages; Lyme disease; Progressive infectious disease

Year:  1991        PMID: 22529711      PMCID: PMC3327997          DOI: 10.1155/1991/902928

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  8 in total

Review 1.  Spirochetal infection of the central nervous system.

Authors:  P K Coyle; R Dattwyler
Journal:  Infect Dis Clin North Am       Date:  1990-12       Impact factor: 5.982

Review 2.  Lyme borreliosis.

Authors:  B J Luft; R J Dattwyler
Journal:  Curr Clin Top Infect Dis       Date:  1989

Review 3.  Cutaneous manifestations in Ixodes-borne Borrelia spirochetosis.

Authors:  E Asbrink; A Hovmark
Journal:  Int J Dermatol       Date:  1987-05       Impact factor: 2.736

4.  Treatment of the early manifestations of Lyme disease.

Authors:  A C Steere; G J Hutchinson; D W Rahn; L H Sigal; J E Craft; E T DeSanna; S E Malawista
Journal:  Ann Intern Med       Date:  1983-07       Impact factor: 25.391

5.  The early clinical manifestations of Lyme disease.

Authors:  A C Steere; N H Bartenhagen; J E Craft; G J Hutchinson; J H Newman; D W Rahn; L H Sigal; P N Spieler; K S Stenn; S E Malawista
Journal:  Ann Intern Med       Date:  1983-07       Impact factor: 25.391

Review 6.  Treatment of Lyme borreliosis.

Authors:  B J Luft; R J Dattwyler
Journal:  Rheum Dis Clin North Am       Date:  1989-11       Impact factor: 2.670

7.  Erythema chronicum migrans of Lyme disease.

Authors:  B W Berger
Journal:  Arch Dermatol       Date:  1984-08

8.  Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis.

Authors:  R J Dattwyler; D J Volkman; S M Conaty; S P Platkin; B J Luft
Journal:  Lancet       Date:  1990-12-08       Impact factor: 79.321

  8 in total
  2 in total

1.  Western Blot as a confirmatory test for Lyme disease.

Authors:  H Artsob
Journal:  Can J Infect Dis       Date:  1993-03

2.  Effect of Borrelia burgdorferi Outer Membrane Vesicles on Host Oxidative Stress Response.

Authors:  Keith Wawrzeniak; Gauri Gaur; Eva Sapi; Alireza G Senejani
Journal:  Antibiotics (Basel)       Date:  2020-05-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.